Sector consensus Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
00:00:02 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 273.00 USD | -1.92% |
|
-6.94% | +36.86% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 281 | +2.93% | 14 | ||||||
| 688.17 | +28.63% | 23 | ||||||
| 251.21 | +23.54% | 20 | ||||||
| 276.28 | +7.38% | 18 | ||||||
| 432.44 | +26.52% | 28 | ||||||
| 268,232.21 | +48.36% | 22 | ||||||
| 270.71 | +20.43% | 20 | ||||||
| 581.83 | -0.23% | 12 | ||||||
| 72.24 | +1.87% | 14 | ||||||
| 185.56 | +11.99% | 16 | ||||||
| 70.73 | -1.88% | 11 | ||||||
| 67.59 | +15.06% | 17 | ||||||
| 50.33 | +21.12% | 11 | ||||||
| 137.98 | +37.56% | 7 | ||||||
| 638.68 | +88.64% | 19 | ||||||
| 136.77 | +16.9% | 22 | ||||||
| 3.909 | -4.23% | 7 | ||||||
| 174.69 | +20.34% | 13 | ||||||
| 84.23 | +51.35% | 22 | ||||||
| 46.13 | +9.5% | 15 | ||||||
| Average | 13,634.14 | +21.29% | 17 | ||||||
| Weighted average by Cap. | 23,369.93 | +22.06% | 19 |
Select your edition
All financial news and data tailored to specific country editions
